BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29684959)

  • 1. [A Case of Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dubé Syndrome].
    Tohi Y; Makita N; Suzuki I; Suzuki R; Fukunaga A; Kubota M; Matsuoka T; Sugino Y; Inoue K; Uehara K; Imai Y; Kawakita M
    Hinyokika Kiyo; 2018 Mar; 64(3):107-110. PubMed ID: 29684959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
    Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DIAGNOSIS OF GENETIC VARIANT CARRIERS IN A PATIENT WITH ASYMPTOMATIC BIRT-HOGG-DUBÉ SYNDROME: A CASE REPORT].
    Watari S; Ichikawa T; Hirasawa A; Shiraishi H; Tokunaga M; Kubota R; Kusumi N; Tsushima T; Shinno Y; Furuya M
    Nihon Hinyokika Gakkai Zasshi; 2023; 114(2):61-65. PubMed ID: 38644188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birt-Hogg-Dubé syndrome: awareness is important!
    Oliveira RC; Tavares E; Sousa V; Figueiredo A
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29066638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple chromophobe and clear cell renal cancer in a patient affected by Birt-Hogg-Dubè syndrome: a case report.
    Castellucci R; Marchioni M; Valenti S; Sortino G; Borgonovo G; Pesenti N; Vismara ACA; Circo MC; Sessa B; Micheli E; Lembo A
    Urologia; 2017 Apr; 84(2):116-120. PubMed ID: 28009417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
    Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
    Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
    Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
    Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
    Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous thermal ablation for renal cell carcinoma in patients with Birt-Hogg-Dubé syndrome.
    Matsui Y; Hiraki T; Gobara H; Iguchi T; Tomita K; Uka M; Araki M; Nasu Y; Furuya M; Kanazawa S
    Diagn Interv Imaging; 2019 Nov; 100(11):671-677. PubMed ID: 31302073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications.
    Jirka GW; Lefler DS; Russo J; Bashir B
    Cancer Biol Ther; 2023 Dec; 24(1):2184153. PubMed ID: 36859772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé Syndrome.
    Iribe Y; Yao M; Tanaka R; Kuroda N; Nagashima Y; Nakatani Y; Furuya M
    Am J Pathol; 2016 Feb; 186(2):337-46. PubMed ID: 26776076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment to Case of bilateral and multifocal renal cell carcinoma associated with Birt-Hogg-Dubé syndrome.
    Kuroda N
    Int J Urol; 2015 Feb; 22(2):231-2. PubMed ID: 25358756
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.
    Zbar B; Alvord WG; Glenn G; Turner M; Pavlovich CP; Schmidt L; Walther M; Choyke P; Weirich G; Hewitt SM; Duray P; Gabril F; Greenberg C; Merino MJ; Toro J; Linehan WM
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):393-400. PubMed ID: 11927500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
    Jikuya R; Johnson TA; Maejima K; An J; Ju YS; Lee H; Ha K; Song W; Kim Y; Okawa Y; Sasagawa S; Kanazashi Y; Fujita M; Imoto S; Mitome T; Ohtake S; Noguchi G; Kawaura S; Iribe Y; Aomori K; Tatenuma T; Komeya M; Ito H; Ito Y; Muraoka K; Furuya M; Kato I; Fujii S; Hamanoue H; Tamura T; Baba M; Suda T; Kodama T; Makiyama K; Yao M; Shuch BM; Ricketts CJ; Schmidt LS; Linehan WM; Nakagawa H; Hasumi H
    EBioMedicine; 2023 Jun; 92():104596. PubMed ID: 37182269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of metastatic renal cell carcinoma associated with Birt-Hogg-Dubé syndrome treated with molecular-targeting agents].
    Nakamura M; Yao M; Sano F; Sakata R; Tatenuma T; Makiyama K; Nakaigawa N; Kubota Y
    Hinyokika Kiyo; 2013 Aug; 59(8):503-6. PubMed ID: 23995526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.